1 Report Overview |
|
1.1 Study Scope |
|
1.2 Key Market Segments |
|
1.3 Players Covered: Ranking by Anti-influenza Drugs Revenue |
|
1.4 Market Analysis by Type |
|
| 1.4.1 Global Anti-influenza Drugs Market Size Growth Rate by Type: 2020 VS 2026 | |
| 1.4.2 Oseltamivir | |
| 1.4.3 Zanamivir | |
| 1.4.4 Peramivir | |
| 1.4.5 Other | |
1.5 Market by Application |
|
| 1.5.1 Global Anti-influenza Drugs Market Share by Application: 2020 VS 2026 | |
| 1.5.2 Children | |
| 1.5.3 Adults | |
| 1.5.4 Elderly | |
1.6 Coronavirus Disease 2019 (Covid-19): Anti-influenza Drugs Industry Impact |
|
| 1.6.1 How the Covid-19 is Affecting the Anti-influenza Drugs Industry | |
| 1.6.1 .1 Anti-influenza Drugs Business Impact Assessment - Covid-19 | |
| 1.6.1 .2 Supply Chain Challenges | |
| 1.6.1 .3 COVID-19's Impact On Crude Oil and Refined Products | |
| 1.6.2 Market Trends and Anti-influenza Drugs Potential Opportunities in the COVID-19 Landscape | |
| 1.6.3 Measures / Proposal against Covid-19 | |
| 1.6.3 .1 Government Measures to Combat Covid-19 Impact | |
| 1.6.3 .2 Proposal for Anti-influenza Drugs Players to Combat Covid-19 Impact | |
1.7 Study Objectives |
|
1.8 Years Considered |
|
2 Global Growth Trends by Regions |
|
2.1 Anti-influenza Drugs Market Perspective (2015-2026) |
|
2.2 Anti-influenza Drugs Growth Trends by Regions |
|
| 轉(zhuǎn)~載自:http://m.hczzz.cn/7/93/2020-2026-Global-Anti-influenza-Drugs-Market-Research-and-Trends-Report.html | |
| 2.2.1 Anti-influenza Drugs Market Size by Regions: 2015 VS 2020 VS 2026 | |
| 2.2.2 Anti-influenza Drugs Historic Market Share by Regions (2015-2020) | |
| 2.2.3 Anti-influenza Drugs Forecasted Market Size by Regions (2021-2026) | |
2.3 Industry Trends and Growth Strategy |
|
| 2.3.1 Market Top Trends | |
| 2.3.2 Market Drivers | |
| 2.3.3 Market Challenges | |
| 2.3.4 Porter's Five Forces Analysis | |
| 2.3.5 Anti-influenza Drugs Market Growth Strategy | |
| 2.3.6 Primary Interviews with Key Anti-influenza Drugs Players (Opinion Leaders) | |
3 Competition Landscape by Key Players |
|
3.1 Global Top Anti-influenza Drugs Players by Market Size |
|
| 3.1.1 Global Top Anti-influenza Drugs Players by Revenue (2015-2020) | |
| 3.1.2 Global Anti-influenza Drugs Revenue Market Share by Players (2015-2020) | |
| 3.1.3 Global Anti-influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) | |
3.2 Global Anti-influenza Drugs Market Concentration Ratio |
|
| 3.2.1 Global Anti-influenza Drugs Market Concentration Ratio (CR5 and HHI) | |
| 3.2.2 Global Top 10 and Top 5 Companies by Anti-influenza Drugs Revenue in 2019 | |
3.3 Anti-influenza Drugs Key Players Head office and Area Served |
|
3.4 Key Players Anti-influenza Drugs Product Solution and Service |
|
3.5 Date of Enter into Anti-influenza Drugs Market |
|
3.6 Mergers & Acquisitions, Expansion Plans |
|
4 Breakdown Data by Type (2015-2026) |
|
4.1 Global Anti-influenza Drugs Historic Market Size by Type (2015-2020) |
|
4.2 Global Anti-influenza Drugs Forecasted Market Size by Type (2021-2026) |
|
5 Anti-influenza Drugs Breakdown Data by Application (2015-2026) |
|
5.1 Global Anti-influenza Drugs Market Size by Application (2015-2020) |
|
5.2 Global Anti-influenza Drugs Forecasted Market Size by Application (2021-2026) |
|
6 North America |
|
6.1 North America Anti-influenza Drugs Market Size (2015-2020) |
|
6.2 Anti-influenza Drugs Key Players in North America (2019-2020) |
|
6.3 North America Anti-influenza Drugs Market Size by Type (2015-2020) |
|
6.4 North America Anti-influenza Drugs Market Size by Application (2015-2020) |
|
7 Europe |
|
7.1 Europe Anti-influenza Drugs Market Size (2015-2020) |
|
7.2 Anti-influenza Drugs Key Players in Europe (2019-2020) |
|
7.3 Europe Anti-influenza Drugs Market Size by Type (2015-2020) |
|
7.4 Europe Anti-influenza Drugs Market Size by Application (2015-2020) |
|
8 China |
|
8.1 China Anti-influenza Drugs Market Size (2015-2020) |
|
8.2 Anti-influenza Drugs Key Players in China (2019-2020) |
|
8.3 China Anti-influenza Drugs Market Size by Type (2015-2020) |
|
8.4 China Anti-influenza Drugs Market Size by Application (2015-2020) |
|
9 Japan |
|
9.1 Japan Anti-influenza Drugs Market Size (2015-2020) |
|
9.2 Anti-influenza Drugs Key Players in Japan (2019-2020) |
|
9.3 Japan Anti-influenza Drugs Market Size by Type (2015-2020) |
|
9.4 Japan Anti-influenza Drugs Market Size by Application (2015-2020) |
|
10 Southeast Asia |
|
10.1 Southeast Asia Anti-influenza Drugs Market Size (2015-2020) |
|
10.2 Anti-influenza Drugs Key Players in Southeast Asia (2019-2020) |
|
10.3 Southeast Asia Anti-influenza Drugs Market Size by Type (2015-2020) |
|
10.4 Southeast Asia Anti-influenza Drugs Market Size by Application (2015-2020) |
|
11 India |
|
11.1 India Anti-influenza Drugs Market Size (2015-2020) |
|
11.2 Anti-influenza Drugs Key Players in India (2019-2020) |
|
11.3 India Anti-influenza Drugs Market Size by Type (2015-2020) |
|
11.4 India Anti-influenza Drugs Market Size by Application (2015-2020) |
|
| 二〇二〇年至2026年全球抗流感藥物市場研究及趨勢報(bào)告 | |
12 Central & South America |
|
12.1 Central & South America Anti-influenza Drugs Market Size (2015-2020) |
|
12.2 Anti-influenza Drugs Key Players in Central & South America (2019-2020) |
|
12.3 Central & South America Anti-influenza Drugs Market Size by Type (2015-2020) |
|
12.4 Central & South America Anti-influenza Drugs Market Size by Application (2015-2020) |
|
13 Key Players Profiles |
|
13.1 Company 1 |
|
| 13.1.1 Company 1 Company Details | |
| 13.1.2 Company 1 Business Overview and Its Total Revenue | |
| 13.1.3 Company 1 Anti-influenza Drugs Introduction | |
| 13.1.4 Company 1 Revenue in Anti-influenza Drugs Business (2015-2020)) | |
| 13.1.5 Company 1 Recent Development | |
13.2 Company 2 |
|
| 13.2.1 Company 2 Company Details | |
| 13.2.2 Company 2 Business Overview and Its Total Revenue | |
| 13.2.3 Company 2 Anti-influenza Drugs Introduction | |
| 13.2.4 Company 2 Revenue in Anti-influenza Drugs Business (2015-2020) | |
| 13.2.5 Company 2 Recent Development | |
13.3 Company 3 |
|
| 13.3.1 Company 3 Company Details | |
| 13.3.2 Company 3 Business Overview and Its Total Revenue | |
| 13.3.3 Company 3 Anti-influenza Drugs Introduction | |
| 13.3.4 Company 3 Revenue in Anti-influenza Drugs Business (2015-2020) | |
| 13.3.5 Company 3 Recent Development | |
13.4 Company 4 |
|
| 13.4.1 Company 4 Company Details | |
| 13.4.2 Company 4 Business Overview and Its Total Revenue | |
| 13.4.3 Company 4 Anti-influenza Drugs Introduction | |
| 13.4.4 Company 4 Revenue in Anti-influenza Drugs Business (2015-2020) | |
| 13.4.5 Company 4 Recent Development | |
13.5 Company 5 |
|
| 13.5.1 Company 5 Company Details | |
| 13.5.2 Company 5 Business Overview and Its Total Revenue | |
| 13.5.3 Company 5 Anti-influenza Drugs Introduction | |
| 13.5.4 Company 5 Revenue in Anti-influenza Drugs Business (2015-2020) | |
| 13.5.5 Company 5 Recent Development | |
13.6 Company 6 |
|
| 13.6.1 Company 6 Company Details | |
| 13.6.2 Company 6 Business Overview and Its Total Revenue | |
| 13.6.3 Company 6 Anti-influenza Drugs Introduction | |
| 13.6.4 Company 6 Revenue in Anti-influenza Drugs Business (2015-2020) | |
| 13.6.5 Company 6 Recent Development | |
14 Analyst's Viewpoints/Conclusions |
|
15 Appendix |
|
15.1 Research Methodology |
|
| 15.1.1 Methodology/Research Approach | |
| 15.1.2 Data Source | |
15.2 Disclaimer |
|
15.3 Author Details |
|
| List of Tables | |
| Table 1. Anti-influenza Drugs Key Market Segments | |
| Table 2. Key Players Covered: Ranking by Anti-influenza Drugs Revenue | |
| Table 3. Ranking of Global Top Anti-influenza Drugs Manufacturers by Revenue (US$ Million) in 2019 | |
| Table 4. Global Anti-influenza Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 | |
| Table 5. Key Players of Oseltamivir | |
| Table 6. Key Players of Zanamivir | |
| Table 7. Key Players of Peramivir | |
| Table 8. Key Players of Other | |
| 二〇二〇年至2026年全球抗流感藥物市場研究及趨勢報(bào)告 | |
| Table 9. COVID-19 Impact Global Market: (Four Anti-influenza Drugs Market Size Forecast Scenarios) | |
| Table 10. Opportunities and Trends for Anti-influenza Drugs Players in the COVID-19 Landscape | |
| Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis | |
| Table 12. Key Regions/Countries Measures against Covid-19 Impact | |
| Table 13. Proposal for Anti-influenza Drugs Players to Combat Covid-19 Impact | |
| Table 14. Global Anti-influenza Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 | |
| Table 15. Global Anti-influenza Drugs Market Size by Regions (US$ Million): 2020 VS 2026 | |
| Table 16. Global Anti-influenza Drugs Market Size by Regions (2015-2020) (US$ Million) | |
| Table 17. Global Anti-influenza Drugs Market Share by Regions (2015-2020) | |
| Table 18. Global Anti-influenza Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) | |
| Table 19. Global Anti-influenza Drugs Market Share by Regions (2021-2026) | |
| Table 20. Market Top Trends | |
| Table 21. Key Drivers: Impact Analysis | |
| Table 22. Key Challenges | |
| Table 23. Anti-influenza Drugs Market Growth Strategy | |
| Table 24. Main Points Interviewed from Key Anti-influenza Drugs Players | |
| Table 25. Global Anti-influenza Drugs Revenue by Players (2015-2020) (Million US$) | |
| Table 26. Global Anti-influenza Drugs Market Share by Players (2015-2020) | |
| Table 27. Global Top Anti-influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-influenza Drugs as of 2019) | |
| Table 28. Global Anti-influenza Drugs by Players Market Concentration Ratio (CR5 and HHI) | |
| Table 29. Key Players Headquarters and Area Served | |
| Table 30. Key Players Anti-influenza Drugs Product Solution and Service | |
| Table 31. Date of Enter into Anti-influenza Drugs Market | |
| Table 32. Mergers & Acquisitions, Expansion Plans | |
| Table 33. Global Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 34. Global Anti-influenza Drugs Market Size Share by Type (2015-2020) | |
| Table 35. Global Anti-influenza Drugs Revenue Market Share by Type (2021-2026) | |
| Table 36. Global Anti-influenza Drugs Market Size Share by Application (2015-2020) | |
| Table 37. Global Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 38. Global Anti-influenza Drugs Market Size Share by Application (2021-2026) | |
| Table 39. North America Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 40. North America Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 41. North America Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 42. North America Anti-influenza Drugs Market Share by Type (2015-2020) | |
| Table 43. North America Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 44. North America Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 45. Europe Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 46. Europe Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 47. Europe Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 48. Europe Anti-influenza Drugs Market Share by Type (2015-2020) | |
| Table 49. Europe Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 50. Europe Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 51. China Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 52. China Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 53. China Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 54. China Anti-influenza Drugs Market Share by Type (2015-2020) | |
| Table 55. China Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 56. China Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 57. Japan Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 58. Japan Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 59. Japan Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 60. Japan Anti-influenza Drugs Market Share by Type (2015-2020) | |
| Table 61. Japan Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 62. Japan Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 63. Southeast Asia Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 64. Southeast Asia Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 65. Southeast Asia Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 66. Southeast Asia Anti-influenza Drugs Market Share by Type (2015-2020) | |
| èr líng èr líng nián zhì 2026 nián quánqiú kàng liúgǎn yàowù shìchǎng yánjiū jí qūshì bàogào | |
| Table 67. Southeast Asia Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 68. Southeast Asia Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 69. India Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 70. India Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 71. India Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 72. India Anti-influenza Drugs Market Share by Type (2015-2020) | |
| Table 73. India Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 74. India Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 75. Central & South America Key Players Anti-influenza Drugs Revenue (2019-2020) (Million US$) | |
| Table 76. Central & South America Key Players Anti-influenza Drugs Market Share (2019-2020) | |
| Table 77. Central & South America Anti-influenza Drugs Market Size by Type (2015-2020) (Million US$) | |
| Table 78. Central & South America Anti-influenza Drugs Market Share by Type (2015-2020) | |
| Table 79. Central & South America Anti-influenza Drugs Market Size by Application (2015-2020) (Million US$) | |
| Table 80. Central & South America Anti-influenza Drugs Market Share by Application (2015-2020) | |
| Table 81. Company 1 Company Details | |
| Table 82. Company 1 Business Overview | |
| Table 83. Company 1 Product | |
| Table 84. Company 1 Revenue in Anti-influenza Drugs Business (2015-2020) (Million US$) | |
| Table 85. Company 1 Recent Development | |
| Table 86. Company 2 Company Details | |
| Table 87. Company 2 Business Overview | |
| Table 88. Company 2 Product | |
| Table 89. Company 2 Revenue in Anti-influenza Drugs Business (2015-2020) (Million US$) | |
| Table 90. Company 2 Recent Development | |
| Table 91. Company 3 Company Details | |
| Table 92. Company 3 Business Overview | |
| Table 93. Company 3 Product | |
| Table 94. Company 3 Revenue in Anti-influenza Drugs Business (2015-2020) (Million US$) | |
| Table 95. Company 3 Recent Development | |
| Table 96. Company 4 Company Details | |
| Table 97. Company 4 Business Overview | |
| Table 98. Company 4 Product | |
| Table 99. Company 4 Revenue in Anti-influenza Drugs Business (2015-2020) (Million US$) | |
| Table 100. Company 4 Recent Development | |
| Table 101. Company 5 Company Details | |
| Table 102. Company 5 Business Overview | |
| Table 103. Company 5 Product | |
| Table 104. Company 5 Revenue in Anti-influenza Drugs Business (2015-2020) (Million US$) | |
| Table 105. Company 5 Recent Development | |
| Table 106. Company 6 Company Details | |
| Table 107. Company 6 Business Overview | |
| Table 108. Company 6 Product | |
| Table 109. Company 6 Revenue in Anti-influenza Drugs Business (2015-2020) (Million US$) | |
| Table 110. Company 6 Recent Development | |
| Table 111. Research Programs/Design for This Report | |
| Table 112. Key Data Information from Secondary Sources | |
| Table 113. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Global Anti-influenza Drugs Market Share by Type: 2020 VS 2026 | |
| Figure 2. Oseltamivir Features | |
| Figure 3. Zanamivir Features | |
| Figure 4. Peramivir Features | |
| Figure 5. Other Features | |
| Figure 6. Global Anti-influenza Drugs Market Share by Application: 2020 VS 2026 | |
| Figure 7. Children Case Studies | |
| Figure 8. Adults Case Studies | |
| Figure 9. Elderly Case Studies | |
| Figure 10. Anti-influenza Drugs Report Years Considered | |
| 2020-2026グローバル抗インフルエンザ薬市場調(diào)査と動(dòng)向レポート | |
| Figure 11. Global Anti-influenza Drugs Market Size YoY Growth 2015-2026 (US$ Million) | |
| Figure 12. Global Anti-influenza Drugs Market Share by Regions: 2020 VS 2026 | |
| Figure 13. Global Anti-influenza Drugs Market Share by Regions (2021-2026) | |
| Figure 14. Porter's Five Forces Analysis | |
| Figure 15. Global Anti-influenza Drugs Market Share by Players in 2019 | |
| Figure 16. Global Top Anti-influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-influenza Drugs as of 2019 | |
| Figure 17. The Top 10 and 5 Players Market Share by Anti-influenza Drugs Revenue in 2019 | |
| Figure 18. North America Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 19. Europe Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 20. China Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 21. Japan Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 22. Southeast Asia Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 23. India Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 24. Central & South America Anti-influenza Drugs Market Size YoY Growth (2015-2020) (Million US$) | |
| Figure 25. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 26. Company 1 Revenue Growth Rate in Anti-influenza Drugs Business (2015-2020) | |
| Figure 27. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 28. Company 2 Revenue Growth Rate in Anti-influenza Drugs Business (2015-2020) | |
| Figure 29. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 30. Company 3 Revenue Growth Rate in Anti-influenza Drugs Business (2015-2020) | |
| Figure 31. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 32. Company 4 Revenue Growth Rate in Anti-influenza Drugs Business (2015-2020) | |
| Figure 33. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 34. Company 5 Revenue Growth Rate in Anti-influenza Drugs Business (2015-2020) | |
| Figure 35. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018 | |
| Figure 36. Company 6 Revenue Growth Rate in Anti-influenza Drugs Business (2015-2020) | |
| Figure 37. Bottom-up and Top-down Approaches for This Report | |
| Figure 38. Data Triangulation | |
| Figure 39. Key Executives Interviewed | |
http://m.hczzz.cn/7/93/2020-2026-Global-Anti-influenza-Drugs-Market-Research-and-Trends-Report.html
略……

如需購買《2020-2026 Global Anti-influenza Drugs Market Research and Trends Report》,編號(hào):2762937
請(qǐng)您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”
請(qǐng)您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網(wǎng)上訂購】 ┊ 下載《訂購協(xié)議》 ┊ 了解“訂購流程”


京公網(wǎng)安備 11010802027365號(hào)